Marshall Wace
EVLO

Marshall Wace’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Marshall Wace’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,940
Closed -$273K – 4720
2021
Q3 		$273K Sell
1,940
-1,190
-38% -$236K ﹤0.01% 2691
2021
Q2 		$861K Sell
3,130
-4,366
-58% -$1.1M ﹤0.01% 1890
2021
Q1 		$1.6M Buy
7,496
+5,427
+262% +$1.5M 0.01% 1430
2020
Q4 		$500K Buy
+2,069
New +$256K ﹤0.01% 1456
2019
Q4 		– Sell
-310
Closed -$38K – 2179
2019
Q3 		$38K Buy
+310
New +$42.6K ﹤0.01% 1530

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return